BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 560861 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)nccc1C#N InChI=1S/C23H22N6O4/c1-15-7-8-17(33-21-20(23(31)32-2)16(13-24)9-10-25-21)14-28(15)22(30)18-5-3-4-6-19(18)29-26-11-12-27-29/h3-6,9-12,15,17H,7-8,14H2,1-2H3 JFNKNPOSXSFDCP-UHFFFAOYSA-N 294306 US9586950, 1 Orexin receptor type 2 Human 0.460 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294306&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673014 381617418 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560862 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)nccc1C#N InChI=1S/C23H22N6O4/c1-15-7-8-17(33-21-20(23(31)32-2)16(13-24)9-10-25-21)14-28(15)22(30)18-5-3-4-6-19(18)29-26-11-12-27-29/h3-6,9-12,15,17H,7-8,14H2,1-2H3 JFNKNPOSXSFDCP-UHFFFAOYSA-N 294306 US9586950, 1 Orexin/Hypocretin receptor type 1 Human 56.0 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294306&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673014 381617418 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560863 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)nccc1C#N InChI=1S/C23H22N6O4/c1-15-7-8-17(33-21-20(23(31)32-2)16(13-24)9-10-25-21)14-28(15)22(30)18-5-3-4-6-19(18)29-26-11-12-27-29/h3-6,9-12,15,17H,7-8,14H2,1-2H3 JFNKNPOSXSFDCP-UHFFFAOYSA-N 294306 US9586950, 1 Orexin receptor type 2 Human 19.0 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294306&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673014 381617418 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560864 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)nccc1C#N InChI=1S/C23H22N6O4/c1-15-7-8-17(33-21-20(23(31)32-2)16(13-24)9-10-25-21)14-28(15)22(30)18-5-3-4-6-19(18)29-26-11-12-27-29/h3-6,9-12,15,17H,7-8,14H2,1-2H3 JFNKNPOSXSFDCP-UHFFFAOYSA-N 294306 US9586950, 1 Orexin/Hypocretin receptor type 1 Human 749 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294306&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673014 381617418 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560865 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)28-34-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 OUZLWHAFYJFYHC-UHFFFAOYSA-N 294333 US9586950, 2 Orexin receptor type 2 Human 0.370 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294333&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673015 381617445 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560866 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)28-34-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 OUZLWHAFYJFYHC-UHFFFAOYSA-N 294333 US9586950, 2 Orexin/Hypocretin receptor type 1 Human 73.8 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294333&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673015 381617445 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560867 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)28-34-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 OUZLWHAFYJFYHC-UHFFFAOYSA-N 294333 US9586950, 2 Orexin receptor type 2 Human 20.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294333&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673015 381617445 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560868 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)28-34-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 OUZLWHAFYJFYHC-UHFFFAOYSA-N 294333 US9586950, 2 Orexin/Hypocretin receptor type 1 Human 584 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294333&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673015 381617445 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560869 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2-n2nccn2)nccc1C#N InChI=1S/C23H23N7O5/c1-14-4-5-16(35-21-19(23(32)34-3)15(12-24)8-9-25-21)13-29(14)22(31)17-6-7-18(33-2)28-20(17)30-26-10-11-27-30/h6-11,14,16H,4-5,13H2,1-3H3 DNWBJZIZUOEOLS-UHFFFAOYSA-N 294334 US9586950, 3::methyl 4-cyano-2-{[(3R,6R)-1-{[6- methoxy-2-(2H-1,2,3-triazol-2- yl)pyridin-3-yl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 1.90 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294334&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673016 381617446 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560870 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2-n2nccn2)nccc1C#N InChI=1S/C23H23N7O5/c1-14-4-5-16(35-21-19(23(32)34-3)15(12-24)8-9-25-21)13-29(14)22(31)17-6-7-18(33-2)28-20(17)30-26-10-11-27-30/h6-11,14,16H,4-5,13H2,1-3H3 DNWBJZIZUOEOLS-UHFFFAOYSA-N 294334 US9586950, 3::methyl 4-cyano-2-{[(3R,6R)-1-{[6- methoxy-2-(2H-1,2,3-triazol-2- yl)pyridin-3-yl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 1419 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294334&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673016 381617446 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560871 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2-n2nccn2)nccc1C#N InChI=1S/C23H23N7O5/c1-14-4-5-16(35-21-19(23(32)34-3)15(12-24)8-9-25-21)13-29(14)22(31)17-6-7-18(33-2)28-20(17)30-26-10-11-27-30/h6-11,14,16H,4-5,13H2,1-3H3 DNWBJZIZUOEOLS-UHFFFAOYSA-N 294334 US9586950, 3::methyl 4-cyano-2-{[(3R,6R)-1-{[6- methoxy-2-(2H-1,2,3-triazol-2- yl)pyridin-3-yl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 33.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294334&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673016 381617446 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560872 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2-n2nccn2)nccc1C#N InChI=1S/C23H23N7O5/c1-14-4-5-16(35-21-19(23(32)34-3)15(12-24)8-9-25-21)13-29(14)22(31)17-6-7-18(33-2)28-20(17)30-26-10-11-27-30/h6-11,14,16H,4-5,13H2,1-3H3 DNWBJZIZUOEOLS-UHFFFAOYSA-N 294334 US9586950, 3::methyl 4-cyano-2-{[(3R,6R)-1-{[6- methoxy-2-(2H-1,2,3-triazol-2- yl)pyridin-3-yl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 10000 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294334&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673016 381617446 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560873 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)17-4-3-5-18(24)20(17)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 RWYALICUGQLFQQ-UHFFFAOYSA-N 294336 US9586950, 4::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.440 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294336&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673017 381617448 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560874 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)17-4-3-5-18(24)20(17)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 RWYALICUGQLFQQ-UHFFFAOYSA-N 294336 US9586950, 4::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 210 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294336&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673017 381617448 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560875 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)17-4-3-5-18(24)20(17)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 RWYALICUGQLFQQ-UHFFFAOYSA-N 294336 US9586950, 4::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 15.7 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294336&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673017 381617448 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560876 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)17-4-3-5-18(24)20(17)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 RWYALICUGQLFQQ-UHFFFAOYSA-N 294336 US9586950, 4::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 1016 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294336&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673017 381617448 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560877 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-6-4-16(24)11-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 AAGLVRULWDBRBK-UHFFFAOYSA-N 294337 US9586950, 5::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.660 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294337 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294337&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673138 381617449 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560878 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-6-4-16(24)11-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 AAGLVRULWDBRBK-UHFFFAOYSA-N 294337 US9586950, 5::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 175 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294337 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294337&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673138 381617449 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560879 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-6-4-16(24)11-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 AAGLVRULWDBRBK-UHFFFAOYSA-N 294337 US9586950, 5::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 21.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294337 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294337&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673138 381617449 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560880 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-6-4-16(24)11-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 AAGLVRULWDBRBK-UHFFFAOYSA-N 294337 US9586950, 5::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 1011 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294337 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294337&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673138 381617449 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560881 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-11-16(24)4-6-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 BSLWIDNJTKEDJE-UHFFFAOYSA-N 294338 US9586950, 6::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.420 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294338&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673139 381617450 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560882 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-11-16(24)4-6-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 BSLWIDNJTKEDJE-UHFFFAOYSA-N 294338 US9586950, 6::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 144 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294338&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673139 381617450 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560883 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-11-16(24)4-6-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 BSLWIDNJTKEDJE-UHFFFAOYSA-N 294338 US9586950, 6::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 18.2 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294338&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673139 381617450 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560884 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-3-5-17(34-21-20(23(32)33-2)15(12-25)7-8-26-21)13-29(14)22(31)18-11-16(24)4-6-19(18)30-27-9-10-28-30/h4,6-11,14,17H,3,5,13H2,1-2H3 BSLWIDNJTKEDJE-UHFFFAOYSA-N 294338 US9586950, 6::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 971 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294338&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673139 381617450 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560885 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)20-17(24)4-3-5-18(20)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 SUZKBNQWQOAXKV-UHFFFAOYSA-N 294339 US9586950, 7::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.330 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294339&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673140 381617451 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560886 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)20-17(24)4-3-5-18(20)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 SUZKBNQWQOAXKV-UHFFFAOYSA-N 294339 US9586950, 7::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 63.0 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294339&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673140 381617451 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560887 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)20-17(24)4-3-5-18(20)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 SUZKBNQWQOAXKV-UHFFFAOYSA-N 294339 US9586950, 7::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 24.0 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294339&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673140 381617451 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560888 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-n2nccn2)nccc1C#N InChI=1S/C23H21FN6O4/c1-14-6-7-16(34-21-19(23(32)33-2)15(12-25)8-9-26-21)13-29(14)22(31)20-17(24)4-3-5-18(20)30-27-10-11-28-30/h3-5,8-11,14,16H,6-7,13H2,1-2H3 SUZKBNQWQOAXKV-UHFFFAOYSA-N 294339 US9586950, 7::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 432 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294339&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673140 381617451 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560889 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 FCYZNQPUQHCMDQ-UHFFFAOYSA-N 294340 US9586950, 8::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.440 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294340&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673141 381617452 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560890 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 FCYZNQPUQHCMDQ-UHFFFAOYSA-N 294340 US9586950, 8::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 153 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294340&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673141 381617452 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560891 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 FCYZNQPUQHCMDQ-UHFFFAOYSA-N 294340 US9586950, 8::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 24.9 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294340&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673141 381617452 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560892 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 FCYZNQPUQHCMDQ-UHFFFAOYSA-N 294340 US9586950, 8::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 1465 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294340&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673141 381617452 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560893 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)29-35-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 KGSOGWGWRGFKSM-UHFFFAOYSA-N 294341 US9586950, 9::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 1.10 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294341&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673142 381617453 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560894 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)29-35-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 KGSOGWGWRGFKSM-UHFFFAOYSA-N 294341 US9586950, 9::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 170 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294341&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673142 381617453 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560895 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)29-35-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 KGSOGWGWRGFKSM-UHFFFAOYSA-N 294341 US9586950, 9::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 38.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294341&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673142 381617453 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560896 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)29-35-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 KGSOGWGWRGFKSM-UHFFFAOYSA-N 294341 US9586950, 9::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 1887 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294341&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673142 381617453 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560897 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)34-28-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 PWNVFCQQEYPYTR-UHFFFAOYSA-N 294342 US9586950, 10::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-(5-methyl-1,2,4- oxadiazol-3- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 0.530 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294342&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673264 381617454 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560898 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)34-28-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 PWNVFCQQEYPYTR-UHFFFAOYSA-N 294342 US9586950, 10::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-(5-methyl-1,2,4- oxadiazol-3- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 86.6 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294342&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673264 381617454 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560899 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)34-28-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 PWNVFCQQEYPYTR-UHFFFAOYSA-N 294342 US9586950, 10::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-(5-methyl-1,2,4- oxadiazol-3- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 6.50 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294342&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673264 381617454 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560900 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H23N5O5/c1-14-8-9-17(33-22-20(24(31)32-3)16(12-25)10-11-26-22)13-29(14)23(30)19-7-5-4-6-18(19)21-27-15(2)34-28-21/h4-7,10-11,14,17H,8-9,13H2,1-3H3 PWNVFCQQEYPYTR-UHFFFAOYSA-N 294342 US9586950, 10::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-(5-methyl-1,2,4- oxadiazol-3- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 698 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294342&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673264 381617454 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560901 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)17-5-4-6-18(25)20(17)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 BHEHAWNZFJGPDP-UHFFFAOYSA-N 294343 US9586950, 11::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.500 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294343 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294343&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673265 381617455 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560902 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)17-5-4-6-18(25)20(17)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 BHEHAWNZFJGPDP-UHFFFAOYSA-N 294343 US9586950, 11::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 128 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294343 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294343&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673265 381617455 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560903 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)17-5-4-6-18(25)20(17)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 BHEHAWNZFJGPDP-UHFFFAOYSA-N 294343 US9586950, 11::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 16.2 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294343 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294343&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673265 381617455 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560904 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)17-5-4-6-18(25)20(17)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 BHEHAWNZFJGPDP-UHFFFAOYSA-N 294343 US9586950, 11::methyl 4-cyano-2-{[(3R,6R)-1-{[3- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 956 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294343 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294343&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673265 381617455 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560905 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 ICGPEGAQYJYXAS-UHFFFAOYSA-N 294344 US9586950, 12::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 1.20 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294344&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673266 381617456 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560906 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 ICGPEGAQYJYXAS-UHFFFAOYSA-N 294344 US9586950, 12::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 332 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294344&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673266 381617456 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560907 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 ICGPEGAQYJYXAS-UHFFFAOYSA-N 294344 US9586950, 12::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 30.2 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294344&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673266 381617456 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560908 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 ICGPEGAQYJYXAS-UHFFFAOYSA-N 294344 US9586950, 12::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 2527 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294344&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673266 381617456 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560909 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 SIYFCWHXKYLKEQ-UHFFFAOYSA-N 294345 US9586950, 13::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.500 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294345&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673267 381617457 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560910 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 SIYFCWHXKYLKEQ-UHFFFAOYSA-N 294345 US9586950, 13::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 117 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294345&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673267 381617457 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560911 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 SIYFCWHXKYLKEQ-UHFFFAOYSA-N 294345 US9586950, 13::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 16.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294345&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673267 381617457 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560912 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)19-10-16(25)5-7-18(19)21-28-14(2)35-29-21/h5,7-10,13,17H,4,6,12H2,1-3H3 SIYFCWHXKYLKEQ-UHFFFAOYSA-N 294345 US9586950, 13::methyl 4-cyano-2-{[(3R,6R)-1-{[5- fluoro-2-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 1028 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294345&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673267 381617457 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560913 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 AZBWVAGPGHWBIQ-UHFFFAOYSA-N 294346 US9586950, 14::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 0.990 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294346&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673268 381617458 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560914 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 AZBWVAGPGHWBIQ-UHFFFAOYSA-N 294346 US9586950, 14::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 188 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294346&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673268 381617458 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560915 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 AZBWVAGPGHWBIQ-UHFFFAOYSA-N 294346 US9586950, 14::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 14.5 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294346&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673268 381617458 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560916 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2noc(C)n2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-7-8-16(34-22-19(24(32)33-3)15(11-26)9-10-27-22)12-30(13)23(31)20-17(5-4-6-18(20)25)21-28-14(2)35-29-21/h4-6,9-10,13,16H,7-8,12H2,1-3H3 AZBWVAGPGHWBIQ-UHFFFAOYSA-N 294346 US9586950, 14::methyl 4-cyano-2-{[(3R,6R)-1-{[2- fluoro-6-(5-methyl-1,2,4-oxadiazol- 3-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 1678 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294346&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673268 381617458 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560917 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 GMYJNZOCFKKDRC-UHFFFAOYSA-N 294347 US9586950, 15::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 2.20 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294347&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673386 381617459 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560918 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 GMYJNZOCFKKDRC-UHFFFAOYSA-N 294347 US9586950, 15::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 405 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294347&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673386 381617459 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560919 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 GMYJNZOCFKKDRC-UHFFFAOYSA-N 294347 US9586950, 15::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin receptor type 2 Human 31.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294347&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673386 381617459 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560920 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2nc(C)no2)nccc1C#N InChI=1S/C24H22FN5O5/c1-13-4-6-17(34-22-20(24(32)33-3)15(11-26)8-9-27-22)12-30(13)23(31)18-7-5-16(25)10-19(18)21-28-14(2)29-35-21/h5,7-10,13,17H,4,6,12H2,1-3H3 GMYJNZOCFKKDRC-UHFFFAOYSA-N 294347 US9586950, 15::methyl 4-cyano-2-{[(3R,6R)-1-{[4- fluoro-2-(3-methyl-1,2,4-oxadiazol- 5-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 3084 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294347&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673386 381617459 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560921 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(C)c2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(21(15)30-27-11-12-28-30)23(31)29-14-18(8-7-16(29)2)34-22-20(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 DOGDMUJTQOKIGC-UHFFFAOYSA-N 294348 US9586950, 16::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[3-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 0.520 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294348&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673387 381617460 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560922 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(C)c2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(21(15)30-27-11-12-28-30)23(31)29-14-18(8-7-16(29)2)34-22-20(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 DOGDMUJTQOKIGC-UHFFFAOYSA-N 294348 US9586950, 16::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[3-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 57.8 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294348&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673387 381617460 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560923 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(C)c2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(21(15)30-27-11-12-28-30)23(31)29-14-18(8-7-16(29)2)34-22-20(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 DOGDMUJTQOKIGC-UHFFFAOYSA-N 294348 US9586950, 16::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[3-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 27.7 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294348&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673387 381617460 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560924 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(C)c2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(21(15)30-27-11-12-28-30)23(31)29-14-18(8-7-16(29)2)34-22-20(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 DOGDMUJTQOKIGC-UHFFFAOYSA-N 294348 US9586950, 16::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[3-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 368 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294348&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673387 381617460 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560925 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(C)cc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-19(20(12-15)30-27-10-11-28-30)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 NPLVYXLBAUOJGN-UHFFFAOYSA-N 294349 US9586950, 17::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[4-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 0.580 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294349&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673388 381617461 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560926 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(C)cc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-19(20(12-15)30-27-10-11-28-30)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 NPLVYXLBAUOJGN-UHFFFAOYSA-N 294349 US9586950, 17::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[4-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 178 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294349&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673388 381617461 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560927 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(C)cc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-19(20(12-15)30-27-10-11-28-30)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 NPLVYXLBAUOJGN-UHFFFAOYSA-N 294349 US9586950, 17::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[4-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 24.3 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294349&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673388 381617461 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560928 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(C)cc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-19(20(12-15)30-27-10-11-28-30)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 NPLVYXLBAUOJGN-UHFFFAOYSA-N 294349 US9586950, 17::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[4-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 1443 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294349&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673388 381617461 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560929 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(C)ccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-20(30-27-10-11-28-30)19(12-15)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 GMYOANCIYHKWNL-UHFFFAOYSA-N 294351 US9586950, 18::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[5-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 0.480 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294351&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673389 381617463 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560930 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(C)ccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-20(30-27-10-11-28-30)19(12-15)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 GMYOANCIYHKWNL-UHFFFAOYSA-N 294351 US9586950, 18::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[5-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 25.8 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294351&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673389 381617463 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560931 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(C)ccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-20(30-27-10-11-28-30)19(12-15)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 GMYOANCIYHKWNL-UHFFFAOYSA-N 294351 US9586950, 18::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[5-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 22.0 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294351&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673389 381617463 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560932 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(C)ccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-4-7-20(30-27-10-11-28-30)19(12-15)23(31)29-14-18(6-5-16(29)2)34-22-21(24(32)33-3)17(13-25)8-9-26-22/h4,7-12,16,18H,5-6,14H2,1-3H3 GMYOANCIYHKWNL-UHFFFAOYSA-N 294351 US9586950, 18::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[5-methyl-2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 311 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294351&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673389 381617463 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560933 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(C)cccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(30-27-11-12-28-30)20(15)23(31)29-14-18(8-7-16(29)2)34-22-21(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 ZQFSBIXAOAXYTA-UHFFFAOYSA-N 294352 US9586950, 19::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-methyl-6-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 0.260 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294352&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73602832 381617464 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560934 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(C)cccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(30-27-11-12-28-30)20(15)23(31)29-14-18(8-7-16(29)2)34-22-21(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 ZQFSBIXAOAXYTA-UHFFFAOYSA-N 294352 US9586950, 19::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-methyl-6-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 37.1 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294352&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73602832 381617464 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560935 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(C)cccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(30-27-11-12-28-30)20(15)23(31)29-14-18(8-7-16(29)2)34-22-21(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 ZQFSBIXAOAXYTA-UHFFFAOYSA-N 294352 US9586950, 19::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-methyl-6-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin receptor type 2 Human 16.9 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294352&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73602832 381617464 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560936 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(C)cccc2-n2nccn2)nccc1C#N InChI=1S/C24H24N6O4/c1-15-5-4-6-19(30-27-11-12-28-30)20(15)23(31)29-14-18(8-7-16(29)2)34-22-21(24(32)33-3)17(13-25)9-10-26-22/h4-6,9-12,16,18H,7-8,14H2,1-3H3 ZQFSBIXAOAXYTA-UHFFFAOYSA-N 294352 US9586950, 19::methyl 4-cyano-2-{[(3R,6R)-6- methyl-1-{[2-methyl-6-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine-3-carboxylate Orexin/Hypocretin receptor type 1 Human 208 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294352&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73602832 381617464 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560937 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin receptor type 2 Human 0.540 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560938 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin/Hypocretin receptor type 1 Human 30.8 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560939 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin receptor type 2 Human 23.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560940 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin/Hypocretin receptor type 1 Human 417 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560941 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)18-5-3-6-19(26)21(18)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 RIKZSZJKZSLKSP-UHFFFAOYSA-N 294354 US9586950, 21::methyl 4-cyano-2-({(3R,6R)-1-[(3- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 1.20 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294354&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673514 381617466 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560942 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)18-5-3-6-19(26)21(18)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 RIKZSZJKZSLKSP-UHFFFAOYSA-N 294354 US9586950, 21::methyl 4-cyano-2-({(3R,6R)-1-[(3- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 174 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294354&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673514 381617466 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560943 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)18-5-3-6-19(26)21(18)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 RIKZSZJKZSLKSP-UHFFFAOYSA-N 294354 US9586950, 21::methyl 4-cyano-2-({(3R,6R)-1-[(3- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 36.3 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294354&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673514 381617466 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560944 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)18-5-3-6-19(26)21(18)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 RIKZSZJKZSLKSP-UHFFFAOYSA-N 294354 US9586950, 21::methyl 4-cyano-2-({(3R,6R)-1-[(3- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 855 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294354&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673514 381617466 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560945 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)19-7-5-17(26)12-20(19)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 GGBAVEZTRXYIOP-UHFFFAOYSA-N 294355 US9586950, 22::methyl 4-cyano-2-({(3R,6R)-1-[(4- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 0.680 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294355&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673515 381617467 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560946 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)19-7-5-17(26)12-20(19)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 GGBAVEZTRXYIOP-UHFFFAOYSA-N 294355 US9586950, 22::methyl 4-cyano-2-({(3R,6R)-1-[(4- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 75.6 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294355&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673515 381617467 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560947 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)19-7-5-17(26)12-20(19)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 GGBAVEZTRXYIOP-UHFFFAOYSA-N 294355 US9586950, 22::methyl 4-cyano-2-({(3R,6R)-1-[(4- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 33.6 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294355&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673515 381617467 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560948 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)19-7-5-17(26)12-20(19)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 GGBAVEZTRXYIOP-UHFFFAOYSA-N 294355 US9586950, 22::methyl 4-cyano-2-({(3R,6R)-1-[(4- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 711 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294355&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673515 381617467 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560949 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)20-12-17(26)5-7-19(20)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 CFIVHPFEXDKGAZ-UHFFFAOYSA-N 294356 US9586950, 23::methyl 4-cyano-2-({(3R,6R)-1-[(5- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 0.470 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294356&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673516 381617468 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560950 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)20-12-17(26)5-7-19(20)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 CFIVHPFEXDKGAZ-UHFFFAOYSA-N 294356 US9586950, 23::methyl 4-cyano-2-({(3R,6R)-1-[(5- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 46.0 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294356&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673516 381617468 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560951 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)20-12-17(26)5-7-19(20)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 CFIVHPFEXDKGAZ-UHFFFAOYSA-N 294356 US9586950, 23::methyl 4-cyano-2-({(3R,6R)-1-[(5- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 32.0 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294356&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673516 381617468 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560952 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-4-6-18(35-23-21(25(33)34-2)16(13-27)8-11-30-23)14-31(15)24(32)20-12-17(26)5-7-19(20)22-28-9-3-10-29-22/h3,5,7-12,15,18H,4,6,14H2,1-2H3 CFIVHPFEXDKGAZ-UHFFFAOYSA-N 294356 US9586950, 23::methyl 4-cyano-2-({(3R,6R)-1-[(5- fluoro-2-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 417 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294356&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673516 381617468 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560953 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)21-18(5-3-6-19(21)26)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 OHYMYLVQQRBIMN-UHFFFAOYSA-N 294357 US9586950, 24::methyl 4-cyano-2-({(3R,6R)-1-[(2- fluoro-6-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 0.420 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294357&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673517 381617469 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560954 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)21-18(5-3-6-19(21)26)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 OHYMYLVQQRBIMN-UHFFFAOYSA-N 294357 US9586950, 24::methyl 4-cyano-2-({(3R,6R)-1-[(2- fluoro-6-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 48.0 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294357&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673517 381617469 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560955 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)21-18(5-3-6-19(21)26)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 OHYMYLVQQRBIMN-UHFFFAOYSA-N 294357 US9586950, 24::methyl 4-cyano-2-({(3R,6R)-1-[(2- fluoro-6-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin receptor type 2 Human 32.8 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294357&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673517 381617469 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560956 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-c2ncccn2)nccc1C#N InChI=1S/C25H22FN5O4/c1-15-7-8-17(35-23-20(25(33)34-2)16(13-27)9-12-30-23)14-31(15)24(32)21-18(5-3-6-19(21)26)22-28-10-4-11-29-22/h3-6,9-12,15,17H,7-8,14H2,1-2H3 OHYMYLVQQRBIMN-UHFFFAOYSA-N 294357 US9586950, 24::methyl 4-cyano-2-({(3R,6R)-1-[(2- fluoro-6-pyrimidin-2- ylphenyl)carbonyl]-6- methylpiperidin-3-yl}oxy)pyridine- 3-carboxylate Orexin/Hypocretin receptor type 1 Human 380 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294357&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673517 381617469 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560957 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin receptor type 2 Human 0.760 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560958 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin/Hypocretin receptor type 1 Human 269 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560959 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin receptor type 2 Human 7.00 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560960 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)nccc1C#N InChI=1S/C25H23N5O4/c1-16-8-9-18(34-23-21(25(32)33-2)17(14-26)10-13-29-23)15-30(16)24(31)20-7-4-3-6-19(20)22-27-11-5-12-28-22/h3-7,10-13,16,18H,8-9,15H2,1-2H3 WTEXMGOAFNNVRP-UHFFFAOYSA-N 294353 US9586950, 20::Methyl 4-cyano-2-({(3R,6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl)oxy}pyridine-3-carboxylate::US9586950, 25 Orexin/Hypocretin receptor type 1 Human 1288 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294353&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673390 381617465 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560961 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C2CCC2)nccc1C#N InChI=1S/C25H27N3O4/c1-16-10-11-19(32-23-22(25(30)31-2)18(14-26)12-13-27-23)15-28(16)24(29)21-9-4-3-8-20(21)17-6-5-7-17/h3-4,8-9,12-13,16-17,19H,5-7,10-11,15H2,1-2H3 KPLRCAPJIDYLAU-UHFFFAOYSA-N 294359 US9586950, 26::Methyl 4-cyano-2-(((3R,6R)-1-(2-cyclobutylbenzoyl)-6-methylpiperidin-3-yl)oxy)nicotinate Orexin receptor type 2 Human 0.260 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294359&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673518 381617470 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560962 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C2CCC2)nccc1C#N InChI=1S/C25H27N3O4/c1-16-10-11-19(32-23-22(25(30)31-2)18(14-26)12-13-27-23)15-28(16)24(29)21-9-4-3-8-20(21)17-6-5-7-17/h3-4,8-9,12-13,16-17,19H,5-7,10-11,15H2,1-2H3 KPLRCAPJIDYLAU-UHFFFAOYSA-N 294359 US9586950, 26::Methyl 4-cyano-2-(((3R,6R)-1-(2-cyclobutylbenzoyl)-6-methylpiperidin-3-yl)oxy)nicotinate Orexin/Hypocretin receptor type 1 Human 241 US Patent 10.7270/Q2GX4DKC aid1795934 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294359&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673518 381617470 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 560963 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C2CCC2)nccc1C#N InChI=1S/C25H27N3O4/c1-16-10-11-19(32-23-22(25(30)31-2)18(14-26)12-13-27-23)15-28(16)24(29)21-9-4-3-8-20(21)17-6-5-7-17/h3-4,8-9,12-13,16-17,19H,5-7,10-11,15H2,1-2H3 KPLRCAPJIDYLAU-UHFFFAOYSA-N 294359 US9586950, 26::Methyl 4-cyano-2-(((3R,6R)-1-(2-cyclobutylbenzoyl)-6-methylpiperidin-3-yl)oxy)nicotinate Orexin receptor type 2 Human 19.3 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294359&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 73673518 381617470 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 560964 COC(=O)c1c(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C2CCC2)nccc1C#N InChI=1S/C25H27N3O4/c1-16-10-11-19(32-23-22(25(30)31-2)18(14-26)12-13-27-23)15-28(16)24(29)21-9-4-3-8-20(21)17-6-5-7-17/h3-4,8-9,12-13,16-17,19H,5-7,10-11,15H2,1-2H3 KPLRCAPJIDYLAU-UHFFFAOYSA-N 294359 US9586950, 26::Methyl 4-cyano-2-(((3R,6R)-1-(2-cyclobutylbenzoyl)-6-methylpiperidin-3-yl)oxy)nicotinate Orexin/Hypocretin receptor type 1 Human 1103 US Patent 10.7270/Q2GX4DKC aid1795935 US9586950 Kuduk, SD; Skudlarek, JW 3/7/2017 3/2/2019 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=294359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=294359&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 73673518 381617470 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6